Penumbra Inc

Medical Education Clinical Program Manager

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, HealthcareIndustries

Requirements

Candidates should possess a Bachelor's degree and have at least 5 years of clinical or medical education experience within the medical device industry, or an equivalent combination of education and experience. Strong clinical and disease state knowledge is desired, particularly in the Neurovascular space. Excellent project management, organizational, and communication skills are essential, along with proficiency in Microsoft Word, Excel, and PowerPoint. The ability to independently manage complex programs, prioritize competing demands, and lead in fast-paced environments is necessary. Previous experience managing a team is preferred.

Responsibilities

The Medical Education Clinical Program Manager will lead the planning, content development, and execution of Medical Education programs across Penumbra’s product lines and therapies, ensuring timely execution of logistics and on-site management without supervision. This role involves strategic oversight of medical education logistics and the delivery of clinically relevant training experiences, ensuring compliance with regulatory standards. The Manager will collaborate with cross-functional teams, including Sales, Marketing, Faculty, and vendors, to deliver impactful education for healthcare professionals. Responsibilities include partnering with faculty, vendors, and Sales to design and execute programs, aligning education with clinical messaging and product strategy, and managing/developing staff. The role also entails leading all aspects of program planning to execution, coordinating logistics, representing Penumbra on-site, building relationships with HCPs and faculty, developing educational content, maintaining knowledge of disease states and products, documenting progress, evaluating program success, and adhering to the Company’s Quality Management System and relevant regulations.

Skills

program management
medical education
content development
logistics
on-site management
regulatory compliance
stakeholder collaboration
training delivery
vendor management
faculty coordination
CE programming
workshops
case observations
vascular
neurovascular
education strategy
clinical messaging
product strategy
mentorship
staff development

Penumbra Inc

Develops medical devices for vascular conditions

About Penumbra Inc

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and the Indigo System, are designed for use in hospitals and clinics, helping healthcare professionals address issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses specifically on these specialized areas, ensuring their products are tailored to the needs of medical professionals in these fields. The company's goal is to continuously improve and innovate their medical devices to enhance patient care and support healthcare providers in delivering effective treatments.

Alameda, CaliforniaHeadquarters
2004Year Founded
$116.7KTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Parental Leave
Paid Vacation
Paid Sick Leave
Paid Holidays

Risks

Recent layoffs in the Immersive Healthcare division may indicate financial strain.
The EMBOLIZE trial could divert resources from core product lines.
Regulatory challenges in Europe may impact sales of new products like BMX81 and BMX96.

Differentiation

Penumbra offers a comprehensive range of neuro and peripheral vascular devices.
The company focuses on innovative solutions for stroke and neurovascular disease treatment.
Penumbra's global presence spans North America, Europe, Asia, and Australia.

Upsides

Growing demand for minimally invasive procedures aligns with Penumbra's product offerings.
The global neurovascular devices market is projected to grow at 8.5% CAGR until 2030.
Penumbra's European launch of BMX81 and BMX96 expands its market presence.

Land your dream remote job 3x faster with AI